CHOP research: GLP-1 RAs may be powerful treatment option for pediatric patients with metabolic dysfunction-associated steatotic liver disease and type 2 diabetes.

CHOP’s new Chief of the Division of Gastroenterology, Hepatology and Nutrition shares her vision for the department’s future.

Amit A. Shah, MD, MSHP, shares why he choose to work with children with liver disease and what makes CHOP’s Pediatric Liver Center stand out. 

For 22 years, collaborative research at CHOP’s Biesecker Pediatric Liver Center has been changing the future for children with serious liver diseases.

Research in the lab and at the bedside offer new hope for young patients with biliary atresia, Alagille syndrome and other chronic liver disorders.

Active research at the Fred and Suzanne Biesecker Pediatric Liver Center.

Read this case study about a patient who received a liver transplant at Children’s Hospital of Philadelphia (CHOP) during COVID-19.

Newborn jaundice is a common pediatric problem. Most instances are benign, and the challenge for clinicians is to determine when further evaluation is needed.